Enhancing effect of PS-K on IL-2-induced lymphocyte activation: possible involvement of antagonistic action against TGF-beta.

Yoshiyuki Yamaguchi(Hiroshima University), Tetsuya Toge(Hiroshima University), Kazuhito Minami(Matsuyama Red Cross Hospital), Akiko Ohshita(Hiroshima University), Kosuke Noma, Yoshiharu Kawabuchi(Hiroshima University)
PubMed
July 19, 2004
Cited by 6

Related Papers

Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The role of Fas ligand and transforming growth factor β in tumor progression
|Cancer|2004|135
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
|Cancer|2004|110